Intestinal microbiota in patients with nonalcoholic fatty liver disease

By M. Mouzaki, E. Comelli, B. Arendt, Julia Bonengel, S. Fung, S. Fischer, I. McGilvray, J. Allard. Hepatology, 2013

707 citations recorded by the source corpus.

Subfields: Epidemiology, Gastroenterology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/67dbe699025aeb873f86c90f00c85329717c989c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. A. Diehl

In Molecular Biology

1. J. Rawls
2. Lawrence A. David

Citations in the corpus

• The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota (2016, background): “pyrosequencing) are available in the literature.((16-18)) In addition, because liver biopsy was not available in all patients to phenotype liver lesions, underdiagnosis of NASH was possible, especially in obese patients.”
• Microbiota in health and diseases (2022, background): “reported that patients with NASH have lower level of Bacteroidetes compared with healthy controls.(318) Raman et al.”
• The Pathophysiology of Gestational Diabetes Mellitus (2018, background): “Similar associations have been observed in obesity [129], T2DM [130], fatty liver disease [131], and elevated total plasma cholesterol [132].”